Invasive breast carcinoma - IARC
Invasive breast carcinoma - IARC
Invasive breast carcinoma - IARC
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Differential diagnosis<br />
The much more common situation of a<br />
cervical squamous cell <strong>carcinoma</strong> extending<br />
into the endometrium must be excluded.<br />
Predominantly squamous diff e re n t i a-<br />
tion of an endometrioid adenocarc i n o m a<br />
must also be excluded before making the<br />
diagnosis of primary pure squamous cell<br />
c a rcinoma of the endometrium.<br />
Prognosis and predictive factors<br />
The prognosis of most squamous cell<br />
<strong>carcinoma</strong>s of the endometrium is rather<br />
poor, although the verrucous variant may<br />
be more favourable.<br />
Transitional cell <strong>carcinoma</strong><br />
Fig. 4.11 Clear cell adeno<strong>carcinoma</strong> of the endometrium. The tumour has a predominantly solid pattern with<br />
occasional poorly formed tubules. The cytoplasm is clear, and cell walls are distinct.<br />
eosinophilic (oncocytic) cytoplasm rather<br />
than the more characteristic clear cytoplasm<br />
{2258,2678}. This cell type may<br />
comprise the entire tumour and make it<br />
difficult to recognize as a clear cell adeno<strong>carcinoma</strong>.<br />
Endometrial clear cell adeno<strong>carcinoma</strong>s<br />
are not graded.<br />
Serous endometrial intraepithelial <strong>carcinoma</strong><br />
may also be seen in association<br />
with clear cell adeno<strong>carcinoma</strong>, and the<br />
associated benign endometrium is generally<br />
atrophic rather than hyperplastic.<br />
Prognosis and predictive factors<br />
Patients with clear cell adeno<strong>carcinoma</strong><br />
are frequently diagnosed in advanced<br />
clinical stages, and, thus, have a poor<br />
p rognosis {24,400,1595,3003}. On the<br />
other hand, clear cell adeno<strong>carcinoma</strong><br />
limited to the uterine corpus has a considerably<br />
better prognosis than serous<br />
adeno<strong>carcinoma</strong> of the same stage.<br />
Mixed adeno<strong>carcinoma</strong><br />
Definition<br />
Mixed adeno<strong>carcinoma</strong> is a tumour composed<br />
of an admixture of a type I<br />
(endometrioid <strong>carcinoma</strong>, including its<br />
variants, or mucinous <strong>carcinoma</strong>) and a<br />
type II <strong>carcinoma</strong> (serous or clear cell) in<br />
which the minor type must comprise at<br />
least 10% of the total volume of the<br />
tumour. The percentage of the minor<br />
component should be stated in the<br />
pathology report. It is generally accepted<br />
that 25% or more of a type II tumour<br />
implies a poor prognosis, although the<br />
significance of lesser proportions is not<br />
well understood {2646,2691}.<br />
Squamous cell <strong>carcinoma</strong><br />
Definition<br />
A primary <strong>carcinoma</strong> of the endometrium<br />
composed of squamous cells of varying<br />
degrees of differentiation.<br />
Epidemiology<br />
Squamous cell <strong>carcinoma</strong> of the<br />
endometrium is uncommon; only about<br />
seventy cases have been re p o rt e d<br />
{2397}.<br />
Clinical features<br />
Squamous cell <strong>carcinoma</strong> of the<br />
endometrium usually occurs in postmenopausal<br />
women and is often associated<br />
with cervical stenosis and pyometra.<br />
Histopathology<br />
Its histological appearance is essentially<br />
identical to that of squamous cell <strong>carcinoma</strong><br />
of the cervix and similarly includes<br />
a rare verrucous variant {2654}.<br />
Definition<br />
A <strong>carcinoma</strong> in which 90% or more is<br />
composed of cells resembling urothelial<br />
transitional cells. Lesser quantities of<br />
transitional cell diff e rentiation would<br />
qualify the tumour as a mixed <strong>carcinoma</strong><br />
with transitional cell differentiation.<br />
Epidemiology<br />
Transitional cell diff e rentiation in<br />
endometrial <strong>carcinoma</strong>s is extre m e l y<br />
uncommon with fewer than 15 cases<br />
reported {1554,1669}. Among patients<br />
with known racial origin, 50% are non-<br />
White (African, Hispanic, or Asian). The<br />
median age is 61.6 years (range 41-83<br />
years).<br />
Clinical features<br />
The main complaint at presentation is<br />
uterine bleeding.<br />
Macroscopy<br />
The tumours are often polypoid or papill<br />
a ry with a mean size of 3.5 cm.<br />
Infiltration of the myometrium is apparent<br />
in some cases.<br />
Histopathology<br />
The transitional cell component is often<br />
grade 2 or 3 and assumes a papillary<br />
configuration. It is always admixed with<br />
another type of <strong>carcinoma</strong>, most often<br />
endometrioid, but it may be clear cell or<br />
s e rous. HPV-associated koilocytotic<br />
changes occur rarely. Only the transitional<br />
cell component invades the<br />
myometrum deeply {1669}. All endometrial<br />
transitional cell <strong>carcinoma</strong>s are negative<br />
for cytokeratin 20 (CK20), but half<br />
a re positive for cytokeratin 7 (CK7)<br />
{1554,1669}.<br />
Differential diagnosis<br />
The diff e rential diagnosis includes<br />
metastatic transitional cell <strong>carcinoma</strong> fro m<br />
226 Tumours of the uterine corpus